Michael Scolaro

Michael Scolaro

Aug 28, 2017

Group 6 Copy 194
0
    Please wait...

    About This Project

    We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Open Insulin

    A team of biohackers is developing the first open source protocol to produce insulin simply and economically...

    How to edit any gene.

    Imagine being able to edit any gene—from Alzheimer's and cancer to eye color and balding. Today, that is almost...

    Can we stop the spread of breast cancer?

    Cancer treatment is a challenging, complex and exhausting process for the patient, their family and medical...

    Backer Badge Funded